Chandan Healthcare Ltd

Chandan Healthcare Ltd

₹ 225 -2.64%
30 Mar 2:28 p.m.
About

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]

Key Points

Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points

  • Market Cap 550 Cr.
  • Current Price 225
  • High / Low 358 / 150
  • Stock P/E 20.3
  • Book Value 55.3
  • Dividend Yield 0.00 %
  • ROCE 28.4 %
  • ROE 25.8 %
  • Face Value 10.0

Pros

  • Company has delivered good profit growth of 71.0% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.4%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Working capital days have increased from 9.16 days to 108 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2024 Sep 2025 Dec 2025
29.52 38.09 35.70
22.13 25.54 25.69
Operating Profit 7.39 12.55 10.01
OPM % 25.03% 32.95% 28.04%
0.05 0.73 -1.38
Interest 0.86 1.06 0.94
Depreciation 1.34 2.40 2.37
Profit before tax 5.24 9.82 5.32
Tax % 31.30% 25.76% 25.38%
3.61 7.28 3.96
EPS in Rs 1.80 2.98 1.62
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
67 56 72 76 100 129
60 51 69 67 74 92
Operating Profit 6 5 3 9 25 37
OPM % 9% 9% 4% 12% 25% 29%
0 0 0 0 1 1
Interest 2 2 2 2 2 4
Depreciation 2 2 2 2 3 6
Profit before tax 2 1 -1 5 21 28
Tax % 39% 45% 93% 23% 24% 26%
1 1 -1 4 16 21
EPS in Rs 0.71 0.41 -0.68 2.02 8.01 8.50
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 14%
3 Years: 22%
TTM: 26%
Compounded Profit Growth
10 Years: %
5 Years: 71%
3 Years: 154%
TTM: 39%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 28%
Return on Equity
10 Years: %
5 Years: 21%
3 Years: 29%
Last Year: 26%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 20 20 20 20 20 24 24
Reserves 4 5 3 7 21 96 111
15 14 15 17 29 33 51
20 18 22 26 23 23 23
Total Liabilities 59 56 59 70 93 177 209
20 20 25 28 44 71 86
CWIP 0 0 0 0 0 4 5
Investments 20 11 14 15 13 10 49
19 25 21 27 37 91 70
Total Assets 59 56 59 70 93 177 209

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-7 7 5 6 -19
7 -10 -2 -15 -36
-0 -2 -2 9 60
Net Cash Flow 0 -4 1 -1 6
Free Cash Flow -7 1 -0 -13 -57
CFO/OP -121% 274% 61% 37% -31%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 54 76 53 77 80 88
Inventory Days 88 78 37 9
Days Payable 126 224 233 399
Cash Conversion Cycle 15 -69 -143 -314 80 88
Working Capital Days -66 -10 -60 -67 -14 108
ROCE % 9% 2% 18% 41% 28%

Insights

In beta
Mar 2023 Mar 2024 Sep 2025
Geographic Presence (States)
Number

Log in to view insights

Please log in to see hidden values.

Login
Number of Diagnostic Centres
Number
Total Patient Count
Lakhs
Total Tests Conducted
Lakhs
Number of Collection Centres
Number
Number of Pharmacy Stores
Number
Pathology Tests Offered
Number
Radiology Tests Offered
Number
Revenue per patient
INR

Shareholding Pattern

Numbers in percentages

3 Recently
Mar 2025Sep 2025Dec 2025
49.43% 49.47% 49.47%
3.86% 1.11% 0.00%
6.32% 5.02% 4.76%
40.38% 44.41% 45.78%
No. of Shareholders 8971,3071,464

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents